Can’t Wait? How to Help Now

blue-pot-1

Things are just about ready with the online donation mechanism.

Until it’s ready to launch – and if you can’t wait to assist research efforts to help say “No!” to hemangiosarcoma – snail mail gifts are always appropriate.

Make your gift – of any amount, all gifts are needed and appreciated – to:

Virginia Tech Foundation (with Stuart’s Fund in the memo line of your check)

and mail to:

Courtney Sibiga or Nena Bauman, Office of Development

Virginia-Maryland College of Veterinary Medicine

205 Duck Pond Drive

Blacksburg, Virginia,  24061

U.S.A.

The Countdown Continues

postcard Stuart_2

We’re ironing out the details of Stuart’s Fund so that you can learn more about Hemangiosarcoma (HSA).

Until this site is entirely up and running, and fundraising mechanisms have been put in place, here’s an intro.

From Dr. Nick Dervisis, DVM, PhD, DACVIM (Oncology) Medical Oncology/Assistant Professor at the Virginia-Maryland College of Veterinary Medicine:

Hemangiosarcoma is an aggressive and common cancer in dogs. While cutaneous masses are often treatable by tumor excision, visceral and cardiac tumors are almost always incurable. Treatment options for this disease have been limited with virtually no significant advances in the last 30 years, mostly due to our poor understanding of the disease biology. While we have thought that HSA originates from neoplastic endothelial cells, accumulating data now suggest a bone marrow progenitor as the cell of origin for this disease. 

 Dr. Erin Fagan, our Medical Oncology Resident is working on exploring a cell signalling pathway in HSA. The Jak/STAT signaling pathway functions to regulate cell growth and proliferation in many normal bone marrow cells. Dysregulation of the Jak/STAT pathway has implications in human malignancies, including leukemias, lymphomas, and sarcomas. To date, there is very little research investigating presence and activity of this pathway in canine HSA. The aim of Dr. Fagan’s study is to identify and characterize the activity of this pathway in hemangiosarcoma. We use archived tumor tissues, from dogs diagnosed with the disease, and interrogate the signaling pathway’s activation status using immunohistochemistry.

Stuart’s Fund helps support this study and more.

Thank you for your interest.

Stay tuned as the countdown continues.

Stay Tuned

Please stay tuned while Stuart’s Fund takes shape.

You’ll soon have the opportunity to help say “no!” to hemangiosarcoma. A terminal canine cancer that abruptly took the life of a nine-year-old Scottish Terrier named Stuart.

Stuart had a big personality. So big, that his memory lives on through friends, family and a special fund created to help answer questions about this devastatingly deadly disease.

Stuart’s life was rich. And his death came completely out of the blue.

Let’s put an end to hemangiosarcoma. Together.